TrialThe New England journal of medicine2012
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
Aleksandar Sekulic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
620 papers cite itlatest 60 shown
this paperpooled ittrialcites it